Adverse and beneficial functions of proteolytic enzymes in skeletal muscle: An overview

Adverse Drug Reactions and Toxicological Reviews

Volumn 21, Issue 1-2, 2002, Pages 31-49

  Mantle, David ^a   Preedy, Victor R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ACETOXYMETHYL 2 (2 CARBOXY 1 PYRROLIDINYLCARBONYL) 7ALPHA METHOXY 8 OXO 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 5,5 DIOXIDE; ANABOLIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALPAIN; CALPASTATIN; CIMATEROL; CLENBUTEROL; CORTICOSTEROID DERIVATIVE; CORTICOSTERONE; DEXAMETHASONE; EGLIN C; ELASTASE INHIBITOR; GROWTH HORMONE; GROWTH PROMOTOR; GUANETHIDINE; LEUPEPTIN; METHYLPREDNISOLONE; MUSCLE ENZYME; NANDROLONE DECANOATE; PREDNISONE; PROTEIN; PROTEINASE; CORTICOSTEROID;

AGING; ALCOHOLISM; APOPTOSIS; CACHEXIA; CANCER; CELL FUNCTION; CLASSIFICATION; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SUBSTRATE; EVIDENCE BASED MEDICINE; EXERCISE; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCULOSKELETAL SYSTEM INFLAMMATION; MYOPATHY; NONHUMAN; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; REVIEW; SEPSIS; SKELETAL MUSCLE; ANIMAL; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; INJURY; METABOLISM; MUSCLE DISEASE; PATHOPHYSIOLOGY;

THIA;

ADRENAL CORTEX HORMONES; AGING; ANIMALS; ENDOPEPTIDASES; EXERCISE; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 0035984736     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256182     Document Type: Review

References (129)

1. Specificity of action of human brain alanyl aminopeptidase on leu-enkephalin and dynorphin-related peptides
2. 2+-activated neutral proteases from human skeletal muscle
3. Purification and characterization of two Cl-activated aminopeptidases hydrolysing basic termini from human skeletal muscle
4. Purification and characterization of the major aminopeptidase from human skeletal muscle
5. Evolutionary families of peptidases
6. Comparison of soluble aminopeptide activities in human cerebral cortex, skeletal muscle and kidney tissues
7. Effect of growth promoters on pig muscle structural protein and proteolytic enzyme levels in vivo and in vitro
8. Comparison of structural protein and proteolytic enzyme levels in degenerating and regenerating rat muscle induced by Notechis scutatus venom
9. Molecular cloning of a novel mammalian calcium dependent protease distinct from both μ- and m-types: Specific expression of the mRNA in skeletal muscle
10. Effect of protease inhibitors and clenbuterol on the in vitro degradation of dystrophin by endogenous proteases in human skeletal muscle
11. Effect of prednisone on protease activities and structural protein levels in rat muscles in vivo
12. Expression and regulation of three lysosomal cysteine protease activities during growth of a differentiating L6 rat myoblast cell line and its nonfusing variant
13. Changes of proteasomes and cathepsin activities and their expression during differentiation of C2 C12 myoblasts
14. Proteasome and myogenesis
15. Differential intracellular distribution and activities of mu- and m-calpains during the differentiation of human myogenic cells in culture
16. An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion
17. Myoblast fusion requires fibronectin degradation by exteriorized m-calpain
18. The calpain-calpastatin system and protein degradation in fusing myoblasts
19. Calpastatin-modulation of m-calpain activity is required for myoblast fusion
20. Effects of thiol protease inhibitors on myoblast fusion and myofibril assembly in vitro
21. A metalloprotease-disintegrin participating in myoblast fusion
22. Developmental control of cathepsin B expression in bovine fetal muscles
23. Skeletal muscle growth of oMT1a-oGH transgenic mice
24. Lower recovery of muscle protein lost during starvation in old rats despite a stimulation of protein synthesis
25. Changes in 20s proteasome activity during ageing of the LOU rat
26. Effects of age and tissue type on the calpain proteolytic system in turkey skeletal muscle
27. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats: Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging
28. Myosin heavy chain isoform and ubiquitin protease mRNA expression after passive leg cycling in persons with spinal cord injury
29. 2+ activated neutral protease with diet and exercise
30. 2+ stimulated protease activity in striated muscle
31. The effect of severe eccentric exercise-induced muscle damage on plasma elastase, glutamine and zinc concentrations
32. Myocellular enzyme leakage, polymorphonuclear neutrophil activation and delayed onset muscle soreness induced by isokinetic eccentric exercise
33. Striated muscle calcium stimulated cysteine protease (calpain-like) activity promotes myeloperoxidase activity with exercise
34. Calpain II expression is increased by changes in mechanical loading of muscle in vivo
35. Acute effect of brief low and high intensity exercise on circulating insulin like growth factor I, II and IC1F
36. Muscle atrophy associated with medial meniscal injury: The effect of clenbuterol
37. The relationship between dietary restriction or clenbuterol treatment on muscle growth and calpain proteinase and calpastatin activities in lambs
38. 2+ dependent proteinases, their specific inhibitor, and cathepsins B and H in skeletal muscle
39. Effect of cimaterol on rabbit growth and myofibrillar protein degradation, and on calcium dependent proteinase and calpastatin activities in skeletal muscle
40. Clenbuterol induced muscle growth: Investigation of possible mediation by insulin
41. Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle
42. Effect of clenbuterol on protease activities and muscle protein levels in innervated and denervated rat skeletal muscle
43. The response of transgenic mice to beta-adrenergic agonist administration is different from that of normal mice
44. Effect of guanethidine-induced adrenergic blockade on the different proteolytic systems in rat skeletal muscle
45. Porcine somatotrophin: Dose titration for maximum growth rate, feed efficiency and lean deposition in swine
46. Influence of time of injection of recombinant porcine somatotrophin relative to time of feeding on growth performance, hormone and metabolite status, and muscle RNA, DNA and protein in pigs
47. A morphological and biochemical study on the actions of corticosteroids on rat skeletal muscle
48. Muscle protein synthesis in patients with rheumatoid arthritis: Effect of chronic corticosteroid therapy on prostaglandin F2a availability
49. Prednisone in Duchenne muscular dystrophy
50. Randomized, double blind six month trial of prednisone in Duchenne muscular dystrophy
51. Effects of glucocorticoid administration on the rate of muscle protein breakdown in vivo on rats as measured by urinary excretion of N-methyl histidine
52. Muscle protein synthesis in steroid induced proximal myopathy: A case report
53. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment
54. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids
55. Glucocorticoids do not regulate the expression of proteolytic genes in skeletal muscle from Cushing's syndrome patients
56. 2+ dependent proteolysis in cultured L6 myotubes
57. Stimulation of myofibrillar protein degradation and expression of mRNA encoding the ubiquitin-proteasome system in C2C12 myotubes by dexamethasone: Effect of the proteasome inhibitor MG 132
58. Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters
59. 2+ activated and ATP ubiquitin dependent proteolytic pathways in skeletal muscle from head trauma patients
60. Mechanisms causing loss of muscle in acute uremia
61. Protease inhibition attenuates microvascular dysfunction in post-ischaemic skeletal muscle
62. Role of neutrophil depletion and elastase inhibition in modifying skeletal muscle reperfusion injury
63. Neutrophil activation after skeletal muscle ischaemia in humans
64. Cathepsin D activity and protein degradation products in organs and blood during experimental declamping shock
65. Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure
66. Activation of capase 3 apoptotic pathways in skeletal muscle fibres in laminin alpha 2 deficient mice
67. DNA fragmentation and apoptosis related proteins of muscle cells in motor neuron disorders
68. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases
69. Seven autosomal recessive limb girdle muscular dystrophies in the Brazilian population: From LGMD2A to LGMD2G
70. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb girdle muscular dystrophy type 2A
71. Mutations of calpain 3 gene in patients with sporadic limb girdle muscular dystrophy in Japan
72. Calpainopathy: A survey of mutations and polymorphisms
73. Clinical, pathological and genetic features of limb girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families
74. Functional defects of a muscle specific calpain, p94, caused by mutations associated with limb girdle muscular dystrophy type 2A
75. Biochemical aspects of muscle disease with particular reference to the muscular dystrophies
76. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition
77. Deletion analysis and calpain status for carrier detection in a family with Duchenne muscular dystrophy
78. Manipulation of the ubiquitin-proteasome pathway in cachexia: Pentoxoifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumour bearing rats
79. Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy
80. A role for mast cells in the progression of Duchenne muscular dystrophy. Correlations in dystrophin deficient humans, dogs and mice
81. Effect of denervation on over development of chloroquine-induced autophagic vacuoles in skeletal muscles
82. Secretion of plasminogen activator and lysosomal enzymes from mouse skeletal muscle: Effect of denervation
83. Lysosomal proteolysis in distally or proximally denervated rat soleus muscle
84. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy
85. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation
86. Stabilisation of neuromuscular junctions by leupeptin increases motor unit size in partially denervated rat muscles
87. Matrix metalloproteinases MMP-2 and MMP-9 in denervated and injured nerve
88. Matrix metalloproteinases MMP-2, MMP-7 and MMP-9 in denervated human muscle
89. Apoptosis-related proteins in skeletal muscle fibres of spinal muscular atrophy
90. Degradative activity of granzyme A on skeletal muscle proteins in vitro: A possible molecular mechanism for muscle fibre damage in polymyositis
91. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies
92. Immunohistochemical localization of chymase, a mast cell marker, and clinical significance in diseased human skeletal muscle
93. Calpain and cathepsins in the skeletal muscle of inflammatory myopathies
94. Ubiquitinated inclusions in inclusion body myositis patients are immunoreactive for cathepsin D but not beta-amyloid
95. Proteasome alpha type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus
96. Autoantibodies in primary Sjogren's syndrome are directed against proteosomal subunit of the alpha and beta type
97. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse
98. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice
99. TNF can directly induce the expression of ubiquitin dependent proteolytic system in rat soleus muscle
100. Interleukin-6 induces proteolysis by activating intracellular proteases in C2 C12 myotubes
101. Protease nexin 1 expression is up-regulated in human skeletal muscle by injury related factors
102. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cacexia
103. A new model of cancer cachexia: Contribution of the ubiquitin-proteasome pathway
104. Mechanism of muscle protein degradation induced by a cancer cachectic cancer
105. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma
106. Pharmacological interference with tissue hypercatabolism in tumour bearing rats
107. Muscle aspartyl protease (cathepsin D) activity: Detection using a chromophoric substrate and relation to wasting in DBA/2 mice implanted with leukemic L1210 tumor cells
108. The expression of genese in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer
109. Regulation of skeletal muscle protein turnover during sepsis
110. Counter regulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle
111. Differential regulation of skeletal muscle protein turnover by insulin and IGF-1 after bacteremia
112. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism
113. Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism
114. 2+ independent proteinase contents in the skeletal muscle in septic rats
115. 2+ activated and ubiquitin-proteasome proteolytic pathways
116. Effect of streptozotocin induced diabetes on growth and proteolytic activity of different muscles in rats
117. Alterations of proteasome activities in skeletal muscle tissue of diabetic rats
118. Ubiquitin conjugation by the N-end rule pathway and mRNA's for its components increase in muscles of diabetics rats
119. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscular wasting
120. Skeletal muscle proteolysis is reduced in non insulin dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy
121. Protein metabolism in alcoholism: Effects on specific tissues and whole body
122. The effect of chronic alcohol ingestion on whole body and muscle protein synthesis - A stable isotope study
123. Chronic alcoholic myopathy: Transcription and translational alterations
124. Chronic ethanol ingestion enhances catabolism and muscle protease activity in acutely uremic rats
125. The effect of chronic ethanol ingestion on synthesis and degradation of soluble, contractile and stromal protein fractions of skeletal muscles from immature and mature rats
126. Investigations into the toxic effects of alcohol on skeletal muscle
127. Studies on the time course of ethanol's acute effects on skeletal muscle protein synthesis: Comparison with acute changes in proteolytic activity
128. Comparative effects of acute ethanol dosage on liver and muscle protein metabolism
129. Effect of ethanol and acetaldehyde on intracellular protease activities in human liver, brain and muscle tissues in vitro